5-Amino-1MQ targets the enzyme, which controls fat metabolism
Unlike GHK-Cu, which has decades of preclinical and some cosmetic data, AHK-Cus peptide-specific evidence is essentially one ex-vivo / in-vitro study [1] , and no study of any kind has injected it
By blocking this enzyme, the molecule preserves the cellular NAD+ pool, supports sirtuin activation, and stimulates energy expenditure through improved mitochondrial function
This age-related NAD+ depletion impairs mitochondrial energy production, reduces SIRT1 activity, compromises DNA repair mechanisms, and accelerates cellular senescence
Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly
Consider the benefits of breastfeeding, the risk of potential infant drug exposure, and the risk of an untreated or inadequately treated condition
